ArticleNature reviews. Nephrology2021
Dispelling the myths of providing dialysis in low- and middle-income countries.
Article in Nature reviews. Nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Nature Medicine Commission on dialysis policy in low- and middle-income countries.Nature medicine · 2026Article
- Quality of Life in Patients with CKD With Catastrophic Health Care Expenditures: A National Study From Thailand.Kidney medicine · 2025Article
- Article
- The International Society of Nephrology Collaborative Quality Framework to Support Safe and Effective Dialysis Provision in Resource-Challenged Settings.Kidney international reports · 2025Article
- International equity in access to home dialysis.Current opinion in nephrology and hypertension · 2025Review
- Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria.Health economics review · 2024Article
- Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda.Cost effectiveness and resource allocation : C/E · 2024Article
- Balancing the health benefits and climate mortality costs of haemodialysis.Future healthcare journal · 2023Article
- Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19.Kidney diseases (Basel, Switzerland) · 2022Review
- Review
- The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai "Peritoneal Dialysis First Policy".Frontiers in public health · 2022Article
- Sustainable Development Goals relevant to kidney health: an update on progress.Nature reviews. Nephrology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.